Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
about
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progressionInteraction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsSuppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signalingPrinciples of interleukin (IL)-6-type cytokine signalling and its regulationRETRACTED: A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysisInhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domainHER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisAkt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptorSpecificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signallingNeuroendocrine differentiation in prostate cancerMutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomasFrom HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cellsInterleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversificationThe importance of nerve microenvironment for schwannoma development.A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerNon-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptorSignaling via Shc family adapter proteinsAn unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cellsA completely foreign receptor can mediate an interferon-gamma-like response.Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligaseDependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivationThe art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.Dysregulated expression of growth factors and their receptors in the development of prostate cancer.How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns.Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.Androgen receptor signalling in the prostate.A weak signal for strong responses: interferon-alpha/beta revisited.Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniaeA phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.Emerging therapeutic targets in chronic heart failure: part II.
P2860
Q22253912-7F566F4C-3133-45EE-A7A1-E05AEC6B2532Q22254244-D5940A7D-E2C7-4D11-A9EA-DBCDB1FBF99CQ24321251-B00B5310-0D5D-45C6-B877-4BCC76B9D765Q24530173-B89A9114-2874-450C-A32A-C8BCDE8E82FDQ24540107-639A3A77-3A12-4E3E-890A-C1197F509721Q24551021-C16E6E26-0BD5-433D-8483-CF19AF7540A6Q24551173-CBCCB9A9-644F-436B-A150-74C4A85AABD9Q24598092-7EB7AFDD-5B9C-47A7-9E94-E38AE91A1A89Q24631156-6CCDED0F-982B-447D-9710-6B68B8A9460BQ24650935-BF561C22-8B7C-4193-B4A9-64EB91BFA8AEQ24657547-665DE515-EC26-4F37-8AB0-5BB84A91A863Q24669579-3E0952DF-36E2-4CBE-9832-EB1D460CB8AFQ24682910-3DCC616E-AF4B-4F72-BB7D-88B75A8B757DQ24746259-9DE339B4-39B6-4A64-B0B8-BF38AE98C386Q24802972-DD121E28-3DCC-4F59-A917-83B76E5800D7Q27321805-6C3E8575-D3BB-4B03-9C5A-EB162BA43B59Q27853127-FFF9AEDC-F493-4871-9A57-07F71F31DF3EQ28140259-B0B02C15-EA24-4828-9CBB-8479C6C7F469Q28199357-4BE7AFB1-01FB-47B0-A6A9-BEDA81CEF045Q28217100-50D16817-5602-404F-B4E2-A8E4D1FCA7B4Q28360432-77D760A2-E65A-4930-A40D-3147434618BEQ28511501-8557D3C9-FDB1-4132-BCFC-036A1CF61660Q28580795-B67B9C49-5FD0-447B-A7E9-5C40D86DBEFBQ33595716-E5D46916-E353-47EB-99E1-BEF714E113A9Q33692379-4FCC84DC-15C5-4C35-9E34-AAB4AA799CBEQ33699124-6ED19DAF-6183-48F0-ABEE-58E9A105EF47Q33807246-61E118DA-CDE2-4C52-8E04-11DFB530D273Q33815922-E784B066-68C9-4552-B6B3-CF10956E417EQ33896008-EE3CF680-2D04-4740-80A6-C44BDEA98EA8Q33912673-75532BCC-9440-4614-B338-8AFD1402865AQ34001080-113CC174-729B-4272-A7BD-25C4B6B31848Q34069375-308DA043-FABD-41DD-B5B0-35EC33579DA1Q34105526-7F6A603F-AC5B-48D8-B92C-F685B32A91C1Q34238056-F8EB6167-9F8D-45D2-929A-7B38503F02D1Q34695953-9EAFF2B9-E801-4848-95B3-6496A18573C1Q34714834-4E6ADE63-D71A-40E9-A4BC-A1024724E379Q34852939-36474C67-4B9A-4AB7-9126-B887C4EAB7C8Q34898930-2C99E5DC-ACFF-4E6B-A5D0-CBD46CFBBDD1Q35001285-173E1421-1E37-4C93-AFCE-341D72DAAF81Q35056026-505E2CA4-4FF3-42FF-9CB1-BCD1DD39D339
P2860
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@ast
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en-gb
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@nl
type
label
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@ast
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en-gb
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@nl
prefLabel
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@ast
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en-gb
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells
@en
P2093
P2860
P2888
P3181
P356
10.1038/30012
P407
P577
1998-05-07T00:00:00Z
P6179
1040525987